Related Experiment Video
Updated: Aug 11, 2026

08:55
Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
The Reverse Calcification Technique (RCT): A Quantitative Parametric Model of Aortic Stenosis Progression
Maya Sharon1, Omer Tal1, Ashraf Hamdan2
1School of Mechanical Engineering, Tel Aviv University, Tel-Aviv, Israel.
Cardiovascular Engineering and Technology
|August 10, 2026
Summary
A new quantitative model predicts calcific aortic valve disease progression using CT scans. This tool aids in personalizing patient follow-up for aortic stenosis, improving early detection and management.
Area of Science:
- Cardiovascular Imaging
- Biomedical Engineering
- Radiology
Background:
- Calcific aortic valve disease (CAVD) causes aortic stenosis (AS) by increasing leaflet stiffness due to calcium deposition.
- Sequential CT scans provide data for tracking AS progression.
- Existing methods lack patient-specific quantitative prediction of CAVD development.
Purpose of the Study:
- To develop and validate a quantitative parametric model for patient-specific prediction of CAVD progression.
- To extend the Reverse Calcification Technique (RCT) by incorporating a time dimension.
- To assess the model's accuracy in predicting aortic valve calcification (AVC) volumes over time.
Main Methods:
- A parametric model was developed using forward prediction and backward reconstruction approaches.
- Seventeen patients with sequential CT scans (1.2-6.5 years) were analyzed.
- Model performance was evaluated using Bland-Altman analysis, t-tests, and relative error calculations.
Main Results:
- Forward prediction showed a mean absolute error of 7.0% for scan intervals under 3 years.
- Backward reconstruction achieved an 8.4% relative error for intervals under 3 years.
- Relative errors increased to 16.8-21.6% for intervals over 3 years, with no systematic bias.
Conclusions:
- The quantitative parametric RCT model is feasible for patient-specific CAVD progression estimation.
- The model shows potential for optimizing patient follow-up intervals.
- External validation and integration of patient-specific risk factors are needed for clinical use.
